February 8, 2022 12:01 PM ESTUpdated February 11, 10:23 AM
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie de­buts Qulip­ta mi­graine TV ads; Lil­ly fo­cus­es on Olympic ath­lete in boy­cotted Games

Beth Snyder Bulik

Senior Editor

Ab­b­Vie launched its first main­stream ad cam­paign for mi­graine pre­ven­tion med Qulip­ta. In two 45-sec­ond TV com­mer­cials, peo­ple are shown staving …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times